Delivery Order SPE2DB22D3004-SPE2DB25FQL32
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Emgality 120 mg/ml Pen Ml, a medication used to treat migraines. The contract has a firm fixed price of $1,729.00 and a period of performance through April 29, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen, a medication used to treat migraine. The contract has a firm fixed price and a ceiling value of $2,074.80, with a period of performance through April 28, 2025. The contract is not set aside and was competitively awarded....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.51 firm-fixed-price contract is for the delivery of Emgality 120 mg/ml pens, a specialty medication used to treat migraines. The award was not set aside for any specific business category. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,263.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/mL pens, a medication used to treat migraine. The contract is a firm fixed-price delivery order, with a period of performance running through March 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY4ER, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,953.00 fixed-price delivery order contract is for the supply of Emgality 120 mg/ml pen injectors, a medication used to treat migraines. The contract has a performance period through May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,739.03, is for the supply of Emgality 120 mg/ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,359.94, is for the delivery of Emgality 120 mg/ml Penml, a medication used for the treatment of migraines. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award, valued at $6,816.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used to treat migraine. This is a firm fixed-price delivery order contract with a period of performance running through January 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $2,464.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/mL Pen, a medication used for the treatment of various medical conditions. The contract has an ultimate completion date of March 13, 2025 and is a Firm Fixed Price Delivery Order. No set-aside was used for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...